Clinetica Biosciences International, Inc. today announced that Mr. Wasim Jalal, has accepted the position of Chief Operating Officer. In this capacity. Wasim will be responsible for the overall management of the corporation's activities with a focus on strategic, tactical, and short-term operations management, including the design, operation, and improvement of the systems that create and deliver value for Clinetica's products and services.
Wasim has been a successful Consulting Practice Leader and Project Delivery Professional through a career that has spanned over 19 years. His diverse experience has been gained through various consulting, project management and corporate roles serving organizations large and small, public and private, on initiatives ranging from the delivery of large-scale complex Supply Chain and ERP projects to instituting organizational change and corporate growth strategies.
In welcoming Mr. Jalal to the Senior Leadership Team at Clinetica, Mr. Mohamed Amin Jagani (President & CEO of Clinetica) commented, "Wasim's strong background in operations management coupled with his impressive credentials and experience in identifying prospects and closing deals will be a great asset to Clinetica".
Wasim holds an Executive MBA from Queen's School of Business, Certified Management Accountant designation (CMA), Certified Management Consultant Designation (CMC) and Project Management Professional (PMP) designation.
This news release contains forward-looking statements that are subject to risks and uncertainties relating to Clinetica's future financial and business performance, as well as any other predictive statements that depend on future events or conditions, or that include words such as "expect," "anticipate," "intend," "plan," "believe," "seek," "may," "will," "estimate" or similar expressions of futurity. You should not place undue reliance on any forward-looking statements, which represent the company's statements only as of the date of this news release and are not intended to give any assurance as to actual future events. Factors that might cause future events to differ include: operational and personnel challenges that could result from management changes; the ability to execute our strategy during management transitions; the ongoing need for early and late phase drug development services; project cancellations and timing issues; our ability to attract and retain qualified personnel; our ability to continue providing our services effectively, including the quality or accuracy of the data or reports provided and our ability to meet agreed-upon schedules; the ability and willingness of our clients to continue to spend on research and development at rates comparable to or greater than historical levels; trends or events affecting the CRO industry and the demand for CRO services; government regulation, including regulatory standards applicable to CRO services; evolving industry standards and technological changes; and general business and economic conditions. Events relating to Clinetica Biosciences, Inc. could differ materially from those anticipated in these forward-looking statements. Although these statements are based upon assumptions company management believes to be reasonable based upon available information, they are subject to the foregoing risks and uncertainties. Please note that Clinetica Biosciences, Inc. assumes no obligation to update any of the forward-looking statements in this release, except as required by applicable local laws and/or regulations. For more information, please contact our investor relations department at ir@clinetica.com.
About Clinetica Biosciences International, Inc.
Clinetica Biosciences International, Inc. is a management
consulting and contract drug development corporation providing strategic consulting,
drug development and support services to clients in the biopharmaceutical
industry. Clinetica applies innovative technologies, therapeutic expertise
and a commitment to quality to help its clients and partners maximize returns
on their R&D investments and accelerate the delivery of safe and effective
therapeutics to patients.
To learn more about Clinetica Biosciences International, Inc. please visit
http://www.clinetica.com or call our
Corporate Headquarters at +1 (877) BIO-PHRM or +1 (877) 246 – 7476.